Bio, fashion IPOs seek to inject life into subdued KOSDAQ SEOUL, July 20 (AJP) — South Korea's KOSDAQ, which turned 30 this month but has fallen 14 percent this year while the KOSPI has surged more than 60 percent, will look to a handful of biotechnology and fashion IPOs this week to revive its subdued listing market. The listings come as the KOSDAQ's fundraising market remains sluggish. Only 25 companies debuted on the exchange in the first half, down from 37 a year earlier, while total IPO proceeds fell to 740 billion won ($534 million July 20, 2026

Four in 10 Korean listed firms face weaker Q2 SEOUL, July 20 (AJP) —Nearly four out of 10 South Korean listed companies are expected to post weaker second-quarter earnings than previously anticipated as the economic fallout from the prolonged Middle East conflict spread across much of corporate Korea, with the windfall from the semiconductor and stock market rally largely confined to a handful of industries. According to financial data provider FnGuide, operating profit forecasts for the April-June quarter were revised lower for 94 July 20, 2026

KOSDAQ-listed battery materials maker seeks Nasdaq debut through SPAC merger SEOUL, July 16 (AJP) - South Korean battery materials maker Enchem on Thursday unveiled its plans to list its U.S. affiliate on Nasdaq through a merger, aiming to tap U.S. capital markets for its North American expansion. The announcement of the plan sent its shares up 17.99 percent to 25,250 won, after the KOSDAQ-listed stock climbed as high as 26,900 won earlier in the day. Under the plan, its U.S. affiliate Enchem America will merge with TLGY Acquisition Corp., a Nasdaq-listed special purpo July 16, 2026

KOSDAQ-listed biotech Alteogen slides amid rival technology concerns SEOUL, July 16 (AJP) - Shares of South Korean biotech company Alteogen have fallen sharply this week after Samsung Bioepis filed a patent application for a similar drug-delivery technology. The move raised concerns that Samsung Bioepis could challenge Alteogen with a competing technology that converts intravenous drugs into subcutaneous injections. Both companies, however, dismissed the concerns, saying the market reaction was excessive and the technologies are not direct competitors. Samsung July 16, 2026

Korean sovereign bonds emerges as Asia's standout bond trade: MarketAxess SEOUL, July 15 (AJP) — While foreign investors have grown increasingly selective across Asia's bond markets, South Korea has emerged as the region's lone standout, attracting uninterrupted monthly inflows into government debt as global funds bet on the country's semiconductor-driven economy and forthcoming inclusion in one of the world's most influential sovereign bond indexes. "Korea has certainly been an interesting market when we look at Korean Treasury Bonds," July 15, 2026

Stricter delisting rules rattle KOSDAQ-listed companies SEOUL, July 14 (AJP) - South Korea's tougher delisting rules are starting to shake up the stock market sooner than expected. Less than two weeks after the new delisting regulations took effect on the South Korean bourse earlier this month, several companies listed on the junior KOSDAQ have already been flagged as at risk of being placed on the Korea Exchange's watchlist. Under the regulations, which took effect July 1, companies whose market capitalization remains below 20 billion won July 14, 2026

Koreans raid retirement savings to chase the stock bull SEOUL, July 14 (AJP) — South Koreans are dipping into pension and long-term funds to join the stock market rush, risking their retirement nest eggs as they chase short-term returns. The number of Koreans cashing out private retirement savings plans jumped 62.7 percent in the first five months of the year from a year earlier, while fund redemptions rose 47.3 percent, according to data submitted by the Financial Supervisory Service (FSS) and the Korea Securities Depository (KSD) released T July 14, 2026

Patriotic retail investors on buying spree to rescue beloved brands from delisting SEOUL, July 13 (AJP) - In a market usually driven by earnings, valuations and future prospects, some South Korean retail investors are making room for something more sentimental: trying to save the companies they grew up with. From a beloved penmaker to a well-known seafood brand, individual investors have rushed to buy shares of struggling companies facing possible delisting. Their buying spree has sent stock prices sharply higher as they try to save familiar brands from disappearing from the July 13, 2026

Ants deserting the KOSDAQ nest for chip harvest SEOUL, July 08 (AJP) — The KOSDAQ has long been the playground of Korea's "ants," the moniker in Korea for retail investors, who dominate the country's junior stock market. Now the colony is on the move. The tech-heavy junior market, which recently turned 30, has retreated more than 10 percent so far this year, ranking among the world's weakest performers, while the benchmark KOSPI has surged more than 82 percent. Its sluggish performance owes much to the desert July 8, 2026

Hot Stock: Hanwha Ocean nosedives 23% upon losing Canadian sub bid SEOUL, July 07 (AJP) — Shares of Hanwha Ocean plunged Tuesday after the South Korean shipbuilder failed to secure preferred bidder status for Canada's next-generation submarine procurement program, dashing investor hopes of winning one of the world's largest submarine export deals. The stock was trading at 89,900 won as of 9:50 a.m., down 22.57 percent from the previous session after triggering a volatility curb shortly after the market opened. Shares of HD Hyundai Heavy Industrie July 7, 2026